Product Name :
Anti-FLT1(Icrucumab Biosimilar) Antibody
Applications:
ELISA,Flow Cyt
Reactivity :
Human FLT1
Conjugate:
Unconjugated
Advantages :
High lot-to-lot consistencyIncreased sensitivity and higher affinityAnimal-free production
Description:
| Description: Anti-FLT1(Icrucumab Biosimilar) Antibody is a biosimilar antibody directed against Human FLT1.{{99011-02-6} MedChemExpress|{99011-02-6} Biological Activity|{99011-02-6} Description|{99011-02-6} manufacturer} | Isotype: Human IgG1 | Conjugate: Unconjugated | Specificity: Human FLT1 | Clonality: Monoclonal | Purity: Recombinant Expression and Affinity purified | Concentration: 1mg/ml | Formation: Liquid, 10mM PBS (pH 7.5) | Storage: Store at –20 °C, (Avoid freeze/thaw cycles)
Description2 :
Anti-FLT1(Icrucumab Biosimilar) Antibody is a biosimilar antibody directed against Human FLT1.{{2225819-06-5} medchemexpress|{2225819-06-5} Purity & Documentation|{2225819-06-5} In Vitro|{2225819-06-5} supplier}
Immunogen:
Host :
Isotype:
Human IgG1
Purity :
Recombinant Expression and Affinity purified
Buffer :
Storage :
Function:
ELISA: 1:5000-1:20000Flow Cyt: 1:200-1:1000Other tested applications.PMID:30252335 Dilution factors are presented in the form of a range because the optimal dilution is a function of many factors, such as antigen density, permeability, etc. The actual dilution used must be determined empirically.
